Abstract
Purpose
Injection of adipose tissue-derived stem cells (ASCs) is a novel method for the treatment of complex perianal fistulas. We aimed to evaluate the safety and efficacy of ASCs in the treatment of complex anal fistulas not associated with Crohn’s disease.
Methods
A phase II clinical trial was performed comparing two different doses of ASCs (group 1: 1 × 107 cells/mL and group 2: 2 × 107 cells/mL). Eligible patients were administered an amount of ASCs proportional to the length of the fistula by injection into the submucosal layer surrounding the internal opening and inside of the fistula tract. ASCs at twice the initial concentration were administered if complete closure was not achieved within 8 weeks. The efficacy endpoint was the complete closure of fistulas 8 weeks after injection. Patients demonstrating complete closure at week 8 were subjected to follow-up for 6 months.
Results
Fifteen patients were injected with ASCs; thirteen completed the study. Complete closure was observed in 69.2% (9/13) of patients at 8 weeks. Three of five patients in group 1, and six of eight in group 2 displayed complete closure; no significant differences were observed between the groups. Six of nine patients who showed complete closure participated in additional follow-up; five (83.3%) showed persistent response at 6 months. No grade 3 or 4 adverse events (AEs) were observed; observed AEs were not related to ASC treatment.
Conclusion
ASCs might be a good option for the treatment of complex perianal fistulas are not healed by conventional operative procedures.
Similar content being viewed by others
References
Parks AG, Stitz RW (1976) The treatment of high fistula-in-ano. Dis Colon Rectum 19(6):487–499
Steele SR, Kumar R, Feingold DL, Rafferty JL, Buie WD, Standards Practice Task Force of the American Society of C, Rectal S (2011) Practice parameters for the management of perianal abscess and fistula-in-ano. Dis Colon Rectum 54(12):1465–1474. doi:10.1097/DCR.0b013e31823122b3
Whiteford MH, Kilkenny J 3rd, Hyman N, Buie WD, Cohen J, Orsay C, Dunn G, Perry WB, Ellis CN, Rakinic J, Gregorcyk S, Shellito P, Nelson R, Tjandra JJ, Newstead G, Standards Practice Task F, American Society of C, Rectal S (2005) Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum 48(7):1337–1342. doi:10.1007/s10350-005-0055-3
Cadeddu F, Salis F, Lisi G, Ciangola I, Milito G (2015) Complex anal fistula remains a challenge for colorectal surgeon. Int J Colorectal Dis 30(5):595–603. doi:10.1007/s00384-014-2104-7
Mizuno H, Zuk PA, Zhu M, Lorenz HP, Benhaim P, Hedrick MH (2002) Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 109(1):199–209 (discussion 210–191)
Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48(7):1416–1423. doi:10.1007/s10350-005-0052-6
Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52(1):79–86. doi:10.1007/DCR.0b013e3181973487
Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D, Group FC (2012) Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Dis Colon Rectum 55(7):762–772. doi:10.1097/DCR.0b013e318255364a
Cho YB, Park KJ, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Jeong HY, Yu CS (2015) Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula. Stem Cells Transl Med 4(5):532–537. doi:10.5966/sctm.2014-0199
Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Yoo HW, Kim I, Ha H, Yu CS (2013) Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula. Stem Cells 31(11):2575–2581. doi:10.1002/stem.1357
Son HJ, Sohn DK, Hong CW, Han KS, Kim BC, Park JW, Choi HS, Chang HJ, Oh JH (2013) Factors associated with complete local excision of small rectal carcinoid tumor. Int J Colorectal Dis 28(1):57–61. doi:10.1007/s00384-012-1538-z
Park KJ, Ryoo SB, Kim JS, Kim TI, Baik SH, Kim HJ, Lee KY, Kim M, Kim WH (2016) Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn’s disease: a pilot clinical trial. Colorectal Dis 18(5):468–476. doi:10.1111/codi.13223
Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63(1):1–12
Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS (2012) Autologous adipose tissue-derived stem cells for the treatment of Crohn’s fistula: a Phase I clinical study. Cell Transplant. doi:10.3727/096368912x656045
Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36(1):77–97
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214
Garcia-Olmo D, Garcia-Arranz M, Garcia LG, Cuellar ES, Blanco IF, Prianes LA, Montes JA, Pinto FL, Marcos DH, Garcia-Sancho L (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy. Int J Colorectal Dis 18(5):451–454. doi:10.1007/s00384-003-0490-3
de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 28(3):313–323. doi:10.1007/s00384-012-1581-9
Garcia-Olmo D, Guadalajara H, Rubio-Perez I, Herreros MD, de-la-Quintana P, Garcia-Arranz M (2015) Recurrent anal fistulae: limited surgery supported by stem cells. World J Gastroenterol 21(11):3330–3336. doi:10.3748/wjg.v21.i11.3330
Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44(3):654–660. doi:10.1016/j.jacc.2004.04.040
Kim YS, Choi YJ, Suh DS, Heo DB, Kim YI, Ryu JS, Koh YG (2015) Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? Am J Sports Med 43(1):176–185. doi:10.1177/0363546514554190
Han EC, Ryoo SB, Oh HK, Choe EK, Moon SH, Park KJ (2014) Crohn’s anal fistula: haw bad is it compared to ordinary non-Crohn’s anal fistula? Colorectal Dis 16(suppl. 3):37–105
Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML (2010) Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19(6):667–679. doi:10.3727/096368910X508762
Papadakis KA, Targan SR (2000) The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 6(4):303–313
Le Blanc K (2006) Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8(6):559–561. doi:10.1080/14653240601045399
Champagne BJ, O’Connor LM, Ferguson M, Orangio GR, Schertzer ME, Armstrong DN (2006) Efficacy of anal fistula plug in closure of cryptoglandular fistulas: long-term follow-up. Dis Colon Rectum 49(12):1817–1821. doi:10.1007/s10350-006-0755-3
Garg P, Song J, Bhatia A, Kalia H, Menon GR (2010) The efficacy of anal fistula plug in fistula-in-ano: a systematic review. Colorectal Dis 12(10):965–970. doi:10.1111/j.1463-1318.2009.01933.x
Zmora O, Mizrahi N, Rotholtz N, Pikarsky AJ, Weiss EG, Nogueras JJ, Wexner SD (2003) Fibrin glue sealing in the treatment of perineal fistulas. Dis Colon Rectum 46(5):584–589. doi:10.1097/01.DCR.0000064697.21308.37
Sentovich SM (2003) Fibrin glue for anal fistulas: long-term results. Dis Colon Rectum 46(4):498–502. doi:10.1097/01.DCR.0000059658.99412.3C
van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG (2006) Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent perianal fistulas: failure of treatment or recurrent patient disease? Int J Colorectal Dis 21(8):784–790. doi:10.1007/s00384-005-0072-7
Schouten WR, Zimmerman DD, Briel JW (1999) Transanal advancement flap repair of transsphincteric fistulas. Dis Colon Rectum 42(11):1419–1422 (discussion 1422–1413)
Acknowledgments
Sang-ji Choi, and Seung-Bum Ryoo contributed equally to this study. This research was sponsored by the Grant of Clinical Research Institute, Seoul National University Hospital (Grant No: 0620102730), from Anterogen Co., Ltd.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The protocol was approved by the institutional review boards at each of the four study sites for compliance with ethical standards and by the Ministry of Food and Drug Safety (IND number: 10844).
Informed consent
Written informed consent was obtained from all patients.
Rights and permissions
About this article
Cite this article
Choi, S., Ryoo, SB., Park, K.J. et al. Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn’s disease: a phase II clinical trial for safety and efficacy. Tech Coloproctol 21, 345–353 (2017). https://doi.org/10.1007/s10151-017-1630-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-017-1630-z